Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Multiple Myeloma 3Immunologic Deficiency Syndromes 2Thalassemia 1Neoplasms 1Myelodysplastic Syndromes 1Muscle Neoplasms 1Metabolic Diseases 1Melanoma 1Lymphoma 1Hemoglobinopathies 1Hematologic Neoplasms 1Fanconi Anemia 1Chronic Pain 1Breast Neoplasms 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

fludarabine 2Surveys and Questionnaires 2fludarabine phosphate 1Thiotepa 1Registries 1Range of Motion, Articular 1Protease Inhibitors 1Melphalan 1Interviews as Topic 1Erythrocyte Count 1Clofarabine 1Bone Marrow Transplantation 1Blood Transfusion 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Anemia, Sickle Cell × Melphalan × Clear all
NCT03609827 2021-10-04

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡